These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2336712)

  • 1. Dissociation of antigenicity and immunogenicity of neonatal epidermal allografts in the mouse.
    Demidem A; Chiller JM; Kanagawa O
    Transplantation; 1990 May; 49(5):966-71. PubMed ID: 2336712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolongation of skin allograft survival after neonatal injection of donor bone marrow and epidermal cells.
    Petit F; Minns AB; Nazzal JA; Hettiaratchy SP; Lantieri LA; Randolph MA; Lee WP
    Plast Reconstr Surg; 2004 Jan; 113(1):270-6. PubMed ID: 14707646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged survival of cultured keratinocyte allografts in the nonimmunosuppressed mouse.
    Hammond EJ; Ng RL; Stanley MA; Munro AJ
    Transplantation; 1987 Jul; 44(1):106-12. PubMed ID: 3299909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that epidermal alloantigen Epa-1 is an immunogen for murine heart as well as skin allograft rejection.
    Steinmuller D; Wakely E; Landas SK
    Transplantation; 1991 Feb; 51(2):459-63. PubMed ID: 1994543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic fibroblasts used to grow cultured epidermal autografts persist in vivo and sensitize the graft recipient for accelerated second-set rejection.
    Hultman CS; Brinson GM; Siltharm S; deSerres S; Cairns BA; Peterson HD; Meyer AA
    J Trauma; 1996 Jul; 41(1):51-8; discussion 58-60. PubMed ID: 8676424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts.
    Erdag G; Morgan JR
    Cell Transplant; 2004; 13(6):701-12. PubMed ID: 15648740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cultured epithelium allografts: Langerhans cell and Thy-1+ dendritic epidermal cell depletion effects on allograft rejection.
    Rouabhia M; Germain L; Bélanger F; Auger FA
    Transplantation; 1993 Aug; 56(2):259-64. PubMed ID: 8102819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Split tolerance to a composite tissue allograft in a swine model.
    Mathes DW; Randolph MA; Solari MG; Nazzal JA; Nielsen GP; Arn JS; Sachs DH; Lee WP
    Transplantation; 2003 Jan; 75(1):25-31. PubMed ID: 12544866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cultured mouse keratinocyte allografts prime for accelerated second set rejection and enhanced cytotoxic lymphocyte response.
    Cairns BA; deSerres S; Matsui M; Frelinger JA; Meyer AA
    Transplantation; 1994 Jul; 58(1):67-72. PubMed ID: 8036710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allograft rejection and immune responses against allogeneic antigens in neonatally thymectomized mice.
    Nomoto K; Mayumi H; Himeno K; Watanabe Y; Mitani M; Tokuda N
    Transplantation; 1986 Feb; 41(2):209-13. PubMed ID: 3511583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rejection of cultured keratinocyte allografts in presensitized mice.
    Kawai K; Ikarashi Y; Tomiyama K; Matsumoto Y; Fujiwara M
    Transplantation; 1993 Aug; 56(2):265-9. PubMed ID: 8356578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rejection, after a slightly prolonged survival time, of Langerhans cell-free allogeneic cultured epidermis used for wound coverage in humans.
    Auböck J; Irschick E; Romani N; Kompatscher P; Höpfl R; Herold M; Schuler G; Bauer M; Huber C; Fritsch P
    Transplantation; 1988 Apr; 45(4):730-7. PubMed ID: 3258682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Observation of expression of ABH blood group antigens in cultured epidermis and its allograft].
    Zhao YB
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1993 Jan; 9(1):34-6, 78. PubMed ID: 8330242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactive delayed-type hypersensitivity in graft recipients: complexity of responses and divergence from acute rejection.
    Sirak J; Orosz CG; Wakely E; VanBuskirk AM
    Transplantation; 1997 May; 63(9):1300-7. PubMed ID: 9158025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival and immunological tolerance of human epidermal allografts produced in culture.
    Thivolet J; Faure M; Demidem A; Mauduit G
    Transplantation; 1986 Sep; 42(3):274-80. PubMed ID: 3750385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of allogeneic epidermis in murine graft rejection.
    Lerner-Tung MB; Hull BE
    J Burn Care Rehabil; 1989; 10(2):151-5. PubMed ID: 2651451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cultured keratinocyte grafts are recognized, but not rejected by CD8+ T cells in vivo.
    Tinois E; Cobbold S; Faure M; Yeoman H; Stanley M
    Eur J Immunol; 1989 Jun; 19(6):1031-5. PubMed ID: 2473908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
    Ohzato H; Monaco AP
    Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of cultured keratinocyte allografts deficient in major histocompatibility complex antigens.
    Hultman CS; Hunt JP; Yamamoto H; Giannopoulos A; deSerres S; Frelinger JA; Meyer AA
    J Trauma; 1998 Jul; 45(1):25-33; discussion 33-4. PubMed ID: 9680007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.